title: Supportive care in neurooncology.
abstract: The quality of life of patients treated for brain tumor is, in all cases, deeply altered by the tumor and the treatments. Optimizing the symptomatic management is a key objective for all care givers. We present in this paper a very pragmatic focus concerning the management of intracranial hypertension (and/or neurological deficits), venous thromboembolism, confusion, epilepsy and symptoms more directly associated with the end of life.
authors: Unité de neurooncologie, service de neurologie, hôpital central, centre hospitalier universitaire, 29 avenue de Lattre-de-Tassigny, Nancy cedex, France. l.taillandier@chu-nancy.fr
authors: L
authors: L
authors: Taillandier
authors: M
authors: M
authors: Blonski
authors: A
authors: A
authors: Darlix
authors: K
authors: K
authors: Hoang Xuan
authors: S
authors: S
authors: Taillibert
authors: S
authors: S
authors: Cartalat Carel
authors: I
authors: I
authors: Piollet
authors: E
authors: E
authors: Le Rhun
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000150:complications / Q000503:physiopathology / Q000523:psychology / Q000628:therapy*; D003221:Confusion / Q000209:etiology / Q000523:psychology / Q000628:therapy; D004827:Epilepsy / Q000209:etiology / Q000523:psychology / Q000628:therapy; D006801:Humans; D019586:Intracranial Hypertension / Q000209:etiology / Q000628:therapy; D008495:Medical Oncology / Q000941:ethics; D010166:Palliative Care; D011788:Quality of Life; D013727:Terminal Care; D020246:Venous Thrombosis / Q000209:etiology / Q000628:therapy
chemical_list: D000925:Anticoagulants